跳至主要内容
临床试验/NCT07253883
NCT07253883尚未招募不适用

A Diagnostic Accuracy Study: N-Tidal Assessment for Respiratory Diagnosis Compared to Using Standard Testing

Liverpool Heart and Chest Hospital NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2026年4月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,200
试验地点
2
主要终点
Diagnostic accuracy of the diagnostic algorithms of N-Tidal Diagnose 1

研究概览

简要总结

The diagnosis of either asthma or chronic obstructive pulmonary disease (COPD) is currently based on a combination of symptoms, different lung tests and sometimes a 'trial by treatment'. Both COPD and Asthma tests currently include forced breathing using a test known as spirometry which can be difficult and uncomfortable for people to perform and needs expert interpretation. Asthma can require multiple tests in sequence which can make the process of diagnosis long and inconvenient for patients. In the UK, there have been challenges providing enough testing for COPD and asthma, in part because the tests are challenging to provide in the community to everyone who needs one.

The STARDUST study aims to test and develop new ways of diagnosing asthma and COPD that are quick, accurate and easy for patient and healthcare professionals to perform. People who have been referred for routine lung testing will breathe normally in and out into a handheld device called the N-Tidal Handset for 75 seconds. This device measures how the level of carbon dioxide (CO2) changes in the breath as people breath through it. The information gathered on the N-Tidal Handsets, called breath records or capnograms, will not be used to alter the diagnosis of any participants in the study.

After the capnograms have been collected, the research team will test 'algorithms' that have been developed using artificial intelligence, to see if they can accurately identify the correct diagnosis. Information collected in the study will also be used to make improvements in these algorithms.

If confirmed to be accurate, these algorithms could be used in clinical practice to help healthcare professionals make faster, more accessible and accurate diagnoses, especially in settings like GP clinics in the community where access to specialist tests may be limited.

详细描述

COPD is one of the leading causes of disability and in the top five causes of death worldwide. Early diagnosis and treatment are essential to slow the decline of lung function and improve quality of life.

The current standard for diagnosing COPD is spirometry; an effort-dependent test that requires supervised use, by a specifically trained medical professional, in a clinic-based environment. It is estimated that up to 2/3 of cases are undiagnosed suggesting that there is a significant care gap in the ability to accurately diagnose COPD.

Asthma is a chronic respiratory disease, characterised by airway inflammation and hyper-responsiveness. In 2019 affected an estimated 262 million people. Early diagnosis and treatment are important to reduce symptoms, exacerbations and mortality and to improve overall quality of life. The confirmation of reversible airflow obstruction using pre- and post-bronchodilator (BD) spirometry is needed to confirm a diagnosis in those suspected as having asthma without evidence of inflammation in the airways or blood.

Spirometry can be challenging for patients to perform, is time consuming and can be challenging to deliver at the scale required by the population.

TidalSense have been developing respiratory diagnostic devices that could offer simpler, safe, fast, reliable and precise tests to diagnose both COPD and asthma.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 110 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Referred for respiratory diagnostic testing with a clinical suspicion of asthma or COPD
  • Participant is willing and able to provide informed consent

排除标准

  • Referred for respiratory diagnostic testing for a condition other than asthma or COPD, with no mention in the referral of a clinical suspicion of COPD or asthma
  • Participants who, in the opinion of the chief investigator, or their delegate, are unlikely to comply with the requirements of the study
  • Inability to give written informed consent
  • Participants who are acutely unwell
  • Patients unable to breathe through their mouths e.g. tracheostomy patients

研究组 & 干预措施

Asthma

Patients with suspected asthma

干预措施: Partial pressure of CO2 during tidal breathing (Diagnostic Test)

Asthma

Patients with suspected asthma

干预措施: FENO (Diagnostic Test)

Asthma

Patients with suspected asthma

干预措施: Spirometry (Diagnostic Test)

COPD

Patients with suspected COPD

干预措施: Partial pressure of CO2 during tidal breathing (Diagnostic Test)

COPD

Patients with suspected COPD

干预措施: FENO (Diagnostic Test)

COPD

Patients with suspected COPD

干预措施: Spirometry (Diagnostic Test)

结局指标

主要结局

Diagnostic accuracy of the diagnostic algorithms of N-Tidal Diagnose 1

时间窗: At time of testing

PPV, NPV, Sensitivity, Specificity compared to clinician diagnosis of COPD

Diagnostic accuracy of prototype diagnostic algorithms

时间窗: At time of testing

Prototype asthma diagnostic algorithms (index test; PPV, NPV, Sensitivity, Specificity) trained using a combined capnogram dataset from this and previous studies, compared to clinician diagnosis of asthma

次要结局

  • Diagnostic accuracy of the N-Tidal Diagnose 1 severity algorithm(At time of diagnosis)
  • Diagnostic accuracy of the N-Tidal Diagnose 1 severity algorithm(At time of diagnsosis)
  • Feasibility and acceptability outcomes(At time of diagnosis)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Study to Understand the Accuracy of a New... | 临床试验